Updates

Press Release

Lupin Limited logo
Lupin LimitedLUPIN · Filed with the exchange

Lupin received U.S.

FDA approval for Modafinil Tablets (100 mg & 200 mg) to treat excessive sleepiness.

This key business development targets a market with estimated annual U.S. sales of USD 7.07 Cr.

Read the original filing(PDF)

No comments yet. Be the first.

More from Lupin Limited

All announcements